Company: CRL
Filing Date: 2025-12-03
Form Type: 8-K
Source: 0001628280-25-054902
Chunk: 1

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-12-03
Form: 8-K
Item: Item 7.01
Chunk 1
---
 Strategy,” “ Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “ Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 28, 2024, and the sections titled “ Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “ Risk Factors,” in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 27, 2025. The Company does not undertake, and assumes no obligation and expressly disclaims any duty, to update or revise its forward-looking statements or any of the information contained in this Current Report on Form 8-K, including related to future events or circumstances except as required by law. New information, future events, or risks may cause the forward-looking events we discuss in this report not to occur.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                            CHARLES RIVER LABORATORIES INTERNATIONAL, INC.                   
  Date:      December 3, 2025      By:      /s/ Matthew L. Daniel                                            
                                            Matthew L. Daniel, Corporate Senior Vice President,              
                                            General Counsel, Corporate Secretary & Chief Compliance Officer